ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Biotherapy Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-36L13266
Home | Market Reports | Health| Health Conditions| Cancer
Global Cancer Biotherapy Market Research Report 2023
BUY CHAPTERS

Global Cancer Biotherapy Market Insights, Forecast to 2030

Code: QYRE-Auto-36L13266
Report
December 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Bristol–Myers Squibb
Celgene
GlaxoSmithKline PLC
Eli Lilly

Cancer Biotherapy Market

Cancer biotherapy is a form of treatment that uses the natural immune system to protect the body against cancer.
Market Analysis and Insights: Global Cancer Biotherapy Market
The global Cancer Biotherapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Cancer Biotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Cancer Biotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Cancer Biotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Cancer Biotherapy include Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline and Eli Lilly, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Cancer Biotherapy is widely used in various fields, such as Hospitals, Diagnostic Laboratories, Research and Academic Laboratories and Pharmaceutical and Biotechnology Companies, etc. Hospitals provides greatest supports to the Cancer Biotherapy industry development. In 2023, global % revenue of Cancer Biotherapy went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Cancer Biotherapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cancer Biotherapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cancer Biotherapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cancer Biotherapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cancer Biotherapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cancer Biotherapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Cancer Biotherapy Market Report

Report Metric Details
Report Name Cancer Biotherapy Market
Segment by Type
Segment by Application
  • Hospitals
  • Diagnostic Laboratories
  • Research and Academic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Eli Lilly
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Cancer Biotherapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cancer Biotherapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Biotherapy revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Cancer Biotherapy Market report?

Ans: The main players in the Cancer Biotherapy Market are Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Eli Lilly

What are the Application segmentation covered in the Cancer Biotherapy Market report?

Ans: The Applications covered in the Cancer Biotherapy Market report are Hospitals, Diagnostic Laboratories, Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies, Others

What are the Type segmentation covered in the Cancer Biotherapy Market report?

Ans: The Types covered in the Cancer Biotherapy Market report are Monoclonal Antibodies, Vaccines, Erythropoietin, Colony Stimulating Factors, Interleukins and Interferons

Recommended Reports

Cancer Drug Therapies

Cancer Therapy Devices

Advanced Oncology Innovations

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Biotherapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Vaccines
1.2.4 Erythropoietin
1.2.5 Colony Stimulating Factors
1.2.6 Interleukins and Interferons
1.3 Market by Application
1.3.1 Global Cancer Biotherapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research and Academic Laboratories
1.3.5 Pharmaceutical and Biotechnology Companies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Biotherapy Market Perspective (2019-2030)
2.2 Global Cancer Biotherapy Growth Trends by Region
2.2.1 Cancer Biotherapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Biotherapy Historic Market Size by Region (2019-2024)
2.2.3 Cancer Biotherapy Forecasted Market Size by Region (2025-2030)
2.3 Cancer Biotherapy Market Dynamics
2.3.1 Cancer Biotherapy Industry Trends
2.3.2 Cancer Biotherapy Market Drivers
2.3.3 Cancer Biotherapy Market Challenges
2.3.4 Cancer Biotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cancer Biotherapy by Players
3.1.1 Global Cancer Biotherapy Revenue by Players (2019-2024)
3.1.2 Global Cancer Biotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Biotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cancer Biotherapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Cancer Biotherapy Market Concentration Ratio
3.4.1 Global Cancer Biotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Biotherapy Revenue in 2023
3.5 Global Key Players of Cancer Biotherapy Head office and Area Served
3.6 Global Key Players of Cancer Biotherapy, Product and Application
3.7 Global Key Players of Cancer Biotherapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Biotherapy Breakdown Data by Type
4.1 Global Cancer Biotherapy Historic Market Size by Type (2019-2024)
4.2 Global Cancer Biotherapy Forecasted Market Size by Type (2025-2030)
5 Cancer Biotherapy Breakdown Data by Application
5.1 Global Cancer Biotherapy Historic Market Size by Application (2019-2024)
5.2 Global Cancer Biotherapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Biotherapy Market Size (2019-2030)
6.2 North America Cancer Biotherapy Market Size by Type
6.2.1 North America Cancer Biotherapy Market Size by Type (2019-2024)
6.2.2 North America Cancer Biotherapy Market Size by Type (2025-2030)
6.2.3 North America Cancer Biotherapy Market Share by Type (2019-2030)
6.3 North America Cancer Biotherapy Market Size by Application
6.3.1 North America Cancer Biotherapy Market Size by Application (2019-2024)
6.3.2 North America Cancer Biotherapy Market Size by Application (2025-2030)
6.3.3 North America Cancer Biotherapy Market Share by Application (2019-2030)
6.4 North America Cancer Biotherapy Market Size by Country
6.4.1 North America Cancer Biotherapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Cancer Biotherapy Market Size by Country (2019-2024)
6.4.3 North America Cancer Biotherapy Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cancer Biotherapy Market Size (2019-2030)
7.2 Europe Cancer Biotherapy Market Size by Type
7.2.1 Europe Cancer Biotherapy Market Size by Type (2019-2024)
7.2.2 Europe Cancer Biotherapy Market Size by Type (2025-2030)
7.2.3 Europe Cancer Biotherapy Market Share by Type (2019-2030)
7.3 Europe Cancer Biotherapy Market Size by Application
7.3.1 Europe Cancer Biotherapy Market Size by Application (2019-2024)
7.3.2 Europe Cancer Biotherapy Market Size by Application (2025-2030)
7.3.3 Europe Cancer Biotherapy Market Share by Application (2019-2030)
7.4 Europe Cancer Biotherapy Market Size by Country
7.4.1 Europe Cancer Biotherapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Cancer Biotherapy Market Size by Country (2019-2024)
7.4.3 Europe Cancer Biotherapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cancer Biotherapy Market Size (2019-2030)
8.2 China Cancer Biotherapy Market Size by Type
8.2.1 China Cancer Biotherapy Market Size by Type (2019-2024)
8.2.2 China Cancer Biotherapy Market Size by Type (2025-2030)
8.2.3 China Cancer Biotherapy Market Share by Type (2019-2030)
8.3 China Cancer Biotherapy Market Size by Application
8.3.1 China Cancer Biotherapy Market Size by Application (2019-2024)
8.3.2 China Cancer Biotherapy Market Size by Application (2025-2030)
8.3.3 China Cancer Biotherapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Cancer Biotherapy Market Size (2019-2030)
9.2 Asia Cancer Biotherapy Market Size by Type
9.2.1 Asia Cancer Biotherapy Market Size by Type (2019-2024)
9.2.2 Asia Cancer Biotherapy Market Size by Type (2025-2030)
9.2.3 Asia Cancer Biotherapy Market Share by Type (2019-2030)
9.3 Asia Cancer Biotherapy Market Size by Application
9.3.1 Asia Cancer Biotherapy Market Size by Application (2019-2024)
9.3.2 Asia Cancer Biotherapy Market Size by Application (2025-2030)
9.3.3 Asia Cancer Biotherapy Market Share by Application (2019-2030)
9.4 Asia Cancer Biotherapy Market Size by Region
9.4.1 Asia Cancer Biotherapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Cancer Biotherapy Market Size by Region (2019-2024)
9.4.3 Asia Cancer Biotherapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cancer Biotherapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Cancer Biotherapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Cancer Biotherapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Cancer Biotherapy Introduction
11.1.4 Amgen Revenue in Cancer Biotherapy Business (2019-2024)
11.1.5 Amgen Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Cancer Biotherapy Introduction
11.2.4 Bristol-Myers Squibb Revenue in Cancer Biotherapy Business (2019-2024)
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Cancer Biotherapy Introduction
11.3.4 Celgene Revenue in Cancer Biotherapy Business (2019-2024)
11.3.5 Celgene Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Cancer Biotherapy Introduction
11.4.4 GlaxoSmithKline Revenue in Cancer Biotherapy Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Cancer Biotherapy Introduction
11.5.4 Eli Lilly Revenue in Cancer Biotherapy Business (2019-2024)
11.5.5 Eli Lilly Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Amgen Inc
Bristol–Myers Squibb
Celgene
GlaxoSmithKline PLC
Eli Lilly
List of Tables
    Table 1. Global Cancer Biotherapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Vaccines
    Table 4. Key Players of Erythropoietin
    Table 5. Key Players of Colony Stimulating Factors
    Table 6. Key Players of Interleukins and Interferons
    Table 7. Global Cancer Biotherapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Cancer Biotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Cancer Biotherapy Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Cancer Biotherapy Market Share by Region (2019-2024)
    Table 11. Global Cancer Biotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Cancer Biotherapy Market Share by Region (2025-2030)
    Table 13. Cancer Biotherapy Market Trends
    Table 14. Cancer Biotherapy Market Drivers
    Table 15. Cancer Biotherapy Market Challenges
    Table 16. Cancer Biotherapy Market Restraints
    Table 17. Global Cancer Biotherapy Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Cancer Biotherapy Revenue Share by Players (2019-2024)
    Table 19. Global Top Cancer Biotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biotherapy as of 2023)
    Table 20. Global Cancer Biotherapy Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Cancer Biotherapy Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Cancer Biotherapy, Headquarters and Area Served
    Table 23. Global Key Players of Cancer Biotherapy, Product and Application
    Table 24. Global Key Players of Cancer Biotherapy, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Cancer Biotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Cancer Biotherapy Revenue Market Share by Type (2019-2024)
    Table 28. Global Cancer Biotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Cancer Biotherapy Revenue Market Share by Type (2025-2030)
    Table 30. Global Cancer Biotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Cancer Biotherapy Revenue Share by Application (2019-2024)
    Table 32. Global Cancer Biotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Cancer Biotherapy Revenue Share by Application (2025-2030)
    Table 34. North America Cancer Biotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Cancer Biotherapy Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Cancer Biotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Cancer Biotherapy Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Cancer Biotherapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Cancer Biotherapy Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Cancer Biotherapy Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Cancer Biotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Cancer Biotherapy Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Cancer Biotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Cancer Biotherapy Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Cancer Biotherapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Cancer Biotherapy Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Cancer Biotherapy Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Cancer Biotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Cancer Biotherapy Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Cancer Biotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Cancer Biotherapy Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Cancer Biotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Cancer Biotherapy Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Cancer Biotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Cancer Biotherapy Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Cancer Biotherapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Cancer Biotherapy Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Cancer Biotherapy Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Cancer Biotherapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Cancer Biotherapy Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Amgen Company Details
    Table 67. Amgen Business Overview
    Table 68. Amgen Cancer Biotherapy Product
    Table 69. Amgen Revenue in Cancer Biotherapy Business (2019-2024) & (US$ Million)
    Table 70. Amgen Recent Developments
    Table 71. Bristol-Myers Squibb Company Details
    Table 72. Bristol-Myers Squibb Business Overview
    Table 73. Bristol-Myers Squibb Cancer Biotherapy Product
    Table 74. Bristol-Myers Squibb Revenue in Cancer Biotherapy Business (2019-2024) & (US$ Million)
    Table 75. Bristol-Myers Squibb Recent Developments
    Table 76. Celgene Company Details
    Table 77. Celgene Business Overview
    Table 78. Celgene Cancer Biotherapy Product
    Table 79. Celgene Revenue in Cancer Biotherapy Business (2019-2024) & (US$ Million)
    Table 80. Celgene Recent Developments
    Table 81. GlaxoSmithKline Company Details
    Table 82. GlaxoSmithKline Business Overview
    Table 83. GlaxoSmithKline Cancer Biotherapy Product
    Table 84. GlaxoSmithKline Revenue in Cancer Biotherapy Business (2019-2024) & (US$ Million)
    Table 85. GlaxoSmithKline Recent Developments
    Table 86. Eli Lilly Company Details
    Table 87. Eli Lilly Business Overview
    Table 88. Eli Lilly Cancer Biotherapy Product
    Table 89. Eli Lilly Revenue in Cancer Biotherapy Business (2019-2024) & (US$ Million)
    Table 90. Eli Lilly Recent Developments
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Biotherapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Cancer Biotherapy Market Share by Type: 2023 VS 2030
    Figure 3. Monoclonal Antibodies Features
    Figure 4. Vaccines Features
    Figure 5. Erythropoietin Features
    Figure 6. Colony Stimulating Factors Features
    Figure 7. Interleukins and Interferons Features
    Figure 8. Global Cancer Biotherapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Cancer Biotherapy Market Share by Application: 2023 VS 2030
    Figure 10. Hospitals Case Studies
    Figure 11. Diagnostic Laboratories Case Studies
    Figure 12. Research and Academic Laboratories Case Studies
    Figure 13. Pharmaceutical and Biotechnology Companies Case Studies
    Figure 14. Others Case Studies
    Figure 15. Cancer Biotherapy Report Years Considered
    Figure 16. Global Cancer Biotherapy Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Cancer Biotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Cancer Biotherapy Market Share by Region: 2023 VS 2030
    Figure 19. Global Cancer Biotherapy Market Share by Players in 2023
    Figure 20. Global Top Cancer Biotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biotherapy as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Cancer Biotherapy Revenue in 2023
    Figure 22. North America Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Cancer Biotherapy Market Share by Type (2019-2030)
    Figure 24. North America Cancer Biotherapy Market Share by Application (2019-2030)
    Figure 25. North America Cancer Biotherapy Market Share by Country (2019-2030)
    Figure 26. United States Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Canada Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Europe Cancer Biotherapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 29. Europe Cancer Biotherapy Market Share by Type (2019-2030)
    Figure 30. Europe Cancer Biotherapy Market Share by Application (2019-2030)
    Figure 31. Europe Cancer Biotherapy Market Share by Country (2019-2030)
    Figure 32. Germany Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. France Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. U.K. Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Italy Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Russia Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Nordic Countries Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. China Cancer Biotherapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. China Cancer Biotherapy Market Share by Type (2019-2030)
    Figure 40. China Cancer Biotherapy Market Share by Application (2019-2030)
    Figure 41. Asia Cancer Biotherapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 42. Asia Cancer Biotherapy Market Share by Type (2019-2030)
    Figure 43. Asia Cancer Biotherapy Market Share by Application (2019-2030)
    Figure 44. Asia Cancer Biotherapy Market Share by Region (2019-2030)
    Figure 45. Japan Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. South Korea Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. China Taiwan Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. India Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Australia Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Cancer Biotherapy Market Size YoY (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Cancer Biotherapy Market Share by Type (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Cancer Biotherapy Market Share by Application (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Cancer Biotherapy Market Share by Country (2019-2030)
    Figure 55. Brazil Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Mexico Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Turkey Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Saudi Arabia Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Israel Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. GCC Countries Cancer Biotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Amgen Revenue Growth Rate in Cancer Biotherapy Business (2019-2024)
    Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biotherapy Business (2019-2024)
    Figure 63. Celgene Revenue Growth Rate in Cancer Biotherapy Business (2019-2024)
    Figure 64. GlaxoSmithKline Revenue Growth Rate in Cancer Biotherapy Business (2019-2024)
    Figure 65. Eli Lilly Revenue Growth Rate in Cancer Biotherapy Business (2019-2024)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Cancer Immunotherapy Market Insights Forecast to 2030
Global Cancer Immunotherapies Market Insights Forecast to 2030
Global Immuno oncology Therapy Market Insights Forecast to 2030
Global Natural Killer Cell Therapy Market Insights Forecast to 2030
Global Natural Killer Cells Therapeutics Market Insights Forecast to 2030
Global Cancer Biologics Market Research Report 2024
Global NK Cell Therapy Market Insights Forecast to 2030
Global Cancer Immunotherapy Drugs Market Research Report 2024
Natural Killer NK Cell Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immunotherapeutic Drugs Market Insights Forecast to 2030
Global Cancer Immunosuppressant Treatment Market Research Report 2024
Global Immunosuppressants in Cancer Therapy Market Research Report 2024
Global Cancer Immuno Personalized Medicine Market Research Report 2024
Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Immuno oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030
Global Immuno Oncology Treatment Market Insights Forecast to 2030
Global Immunotherapy Drugs Market Research Report 2024
Global Tumor Immune Cell Therapy Market Research Report 2024
Global Immuno Cell Therapy Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions